MindMed Archives

Psychedelics News

MindMed

Breaking News, Finance

18 Aug 2022

Breaking News: MindMed Stock Jumps Over 60%

Investors woke up this morning to a serious shroom stock buzz....

By Jason Najum

Breaking News, Industry

12 Aug 2022

Breaking News: MindMed Halts 18-MC (MM-110) Opioid Withdrawal Program

Yesterday MindMed released its financial results and held its earnings call, announcing the shelving of its 18-MC (MM-110) program for opioid withdrawal....

By Jason Najum

Industry

5 Aug 2022

MindMed Announces 1:15 Reverse Stock Split

According to the press release: “The reverse share split is intended to enable the Company to achieve several important corporate objectives, give the Company greater flexibility in considering and planning...

By Microdose NewsDesk

Industry

22 Jul 2022

A Deeper Look at MindMed’s Corporate Update

MindMed has released its Corporate Overview....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

27 Jun 2022

Compass Wins Patent Case; MindMed Granted Patent For MDMA and LSD

Compass Pathways and MindMed get patent wins in controversial patent claims...

By Jason Najum

Industry

3 Jun 2022

The Top Clinical Trials in 2022

2022 is expected to be a pivotal year, with the psychedelic industry attempting to solidify itself as a commercially viable endeavor....

By Jason Najum

Industry

19 May 2022

MindMed Releases Phase 1 Trial Results For Opioid Addiction

MindMed Reports Topline Data From Phase 1 Trial of MM-110 in Development for the Treatment of Opioid Withdrawal...

By Jason Najum

Finance

17 May 2022

MindMed Prepares to Raise Up to $100M in Capital

MindMed announced the approval for shares to be sold for up to $100,000,000 in aggregate sales in "at the market" transactions (at market price)...

By Microdose NewsDesk

Don’t Miss

16 May 2022

News You Might Have Missed: May 16th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result